CryoEM structure of an MHC-I/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading

Y Yi Sun R Ruth A. Pumroy (Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania) L Leena Mallik (Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania) A Apala Chaudhuri (Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania) C Chloe Wang (Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania) D Daniel Hwang J Julia N. Danon (Center for Computational and Genomic Medicine and Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia) K Kimia Dasteh Goli (Center for Computational and Genomic Medicine and Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia) V Vera Y. Moiseenkova-Bell (Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania) N Nikolaos G. Sgourakis

Abstract

Class I major histocompatibility complex (MHC-I) proteins play a pivotal role in adaptive immunity by displaying epitopic peptides to CD8+ T cells. The chaperones tapasin and TAPBPR promote the selection of immunogenic antigens from a large pool of intracellular peptides. Interactions of chaperoned MHC-I molecules with incoming peptides are transient in nature, and as a result, the precise antigen proofreading mechanism remains elusive. Here, we leverage a high-fidelity TAPBPR variant and conformationally stabilized MHC-I, to determine the solution structure of the human antigen editing complex bound to a peptide decoy by cryogenic electron microscopy (cryo-EM) at an average resolution of 3.0 Å. Antigen proofreading is mediated by transient interactions formed between the nascent peptide binding groove with the P2/P3 peptide anchors, where conserved MHC-I residues stabilize incoming peptides through backbone-focused contacts. Finally, using our high-fidelity chaperone, we demonstrate robust peptide exchange on the cell surface across multiple clinically relevant human MHC-I allomorphs. Our work has important ramifications for understanding the selection of immunogenic epitopes for T cell screening and vaccine design applications.

Article Details

Volume / Issue Vol. 122, Issue 2
Published January 14, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

Y

Yi Sun

R

Ruth A. Pumroy

Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania

L

Leena Mallik

Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania

A

Apala Chaudhuri

Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania

C

Chloe Wang

Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania

D

Daniel Hwang

J

Julia N. Danon

Center for Computational and Genomic Medicine and Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia

K

Kimia Dasteh Goli

Center for Computational and Genomic Medicine and Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia

V

Vera Y. Moiseenkova-Bell

Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania

N

Nikolaos G. Sgourakis